Cargando…

Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?

Detalles Bibliográficos
Autores principales:	Ippolito, Matthew M, Flexner, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314247/ https://www.ncbi.nlm.nih.gov/pubmed/32474576 http://dx.doi.org/10.1093/cid/ciaa691

Ejemplares similares

Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment
por: Carbillon, Lionel, et al.
Publicado: (2021)

Hydroxychloroquine serum concentration in coronavirus disease 2019 (COVID-19) patients: a retrospective study
por: Zohra, Saadi Fatima, et al.
Publicado: (2021)

Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease
por: Simpson, Megan, et al.
Publicado: (2020)

Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication
por: Hong, Kyung Soo, et al.
Publicado: (2020)

Hydroxychloroquine: small effects in mild disease
por: Levantovsky, Rachel, et al.
Publicado: (2020)

Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
por: Ayoubkhani, Daniel, et al.
Publicado: (2022)

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019
por: Sridhar, Arun R., et al.
Publicado: (2020)

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
por: Sahraei, Zahra, et al.
Publicado: (2020)

Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019
por: Kim, Ji-Won, et al.
Publicado: (2022)

Case Series of Patients with Coronavirus Disease 2019 Pneumonia Treated with Hydroxychloroquine
por: Tanaka, Tomohiro, et al.
Publicado: (2023)

Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study
por: Eijmael, Marjella, et al.
Publicado: (2021)

Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection
por: Martinez, Mario A, et al.
Publicado: (2022)

High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
por: Cao, Wei, et al.
Publicado: (2020)

Open-label randomized control trial of hydroxychloroquine in patients with moderate to severe coronavirus disease 2019 infection
por: Gupta, Salil, et al.
Publicado: (2021)

What are the sources of exposure in healthcare personnel with coronavirus disease 2019 infection?
por: Zabarsky, Trina F., et al.
Publicado: (2021)

Secondary Bacterial Infections in Critical Ill Patients With Coronavirus Disease 2019
por: Fu, Yiqi, et al.
Publicado: (2020)

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2023)

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease
por: Satlin, Michael J., et al.
Publicado: (2020)

Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure
por: Rakedzon, Stav, et al.
Publicado: (2020)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
por: Bansal, Pankaj, et al.
Publicado: (2020)

In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses
por: Kang, Chang Kyung, et al.
Publicado: (2020)

Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections
por: Sweeney, Daniel A, et al.
Publicado: (2023)

Coronavirus Disease 2019: Associated Multiple Organ Damage
por: Collange, Olivier, et al.
Publicado: (2020)

Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine
por: Yang, Jinyoung, et al.
Publicado: (2023)

Optimal timing of tracheostomy in patients on veno‐venous extracorporeal membrane oxygenation for coronavirus 2019: a case series
por: Matsuyoshi, Takeo, et al.
Publicado: (2021)

An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019
por: Bordoni, Veronica, et al.
Publicado: (2020)

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring
por: Ramireddy, Archana, et al.
Publicado: (2020)

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)

A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine
por: Mukherjee, Aveek, et al.
Publicado: (2020)

Regarding: “Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019”
por: McCullough, Peter A.
Publicado: (2021)

Characteristics of Postvaccination Coronavirus Disease 2019 Hospitalizations Prior to Booster Vaccines
por: Moffa, Matthew A, et al.
Publicado: (2022)

Cohabitation With a Known Coronavirus Disease 2019 Case Is Associated With Greater Antibody Concentration and Symptom Severity in a Community-Based Sample of Seropositive Adults
por: Schrock, Joshua M, et al.
Publicado: (2021)

A teenager with CHD and coronavirus disease 2019
por: Olfe, Jakob, et al.
Publicado: (2020)

Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization
por: Thémans, Pauline, et al.
Publicado: (2020)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Coronavirus Disease 2019 Mitigation Strategies Were Associated With Decreases in Other Respiratory Virus Infections
por: Sinha, Pranay, et al.
Publicado: (2021)

Natriuretic Peptide Levels and Clinical Outcomes Among Patients Hospitalized With Coronavirus Disease 2019 Infection
por: Aslam, M. Imran, et al.
Publicado: (2021)

Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
por: Velasco, María, et al.
Publicado: (2021)

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
por: Garcia, Philippe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mfr41umaaldqt714hfv09i9ptk